Cargando…
Poor local control of ulcerative T1 glottic cancer treated with 2.25-Gy per fraction radiotherapy
The Tokai Study Group for Therapeutic Radiology and Oncology (TOSTRO) started managing T1 glottic cancer using 2.25 Gy/fraction radiotherapy in 2011. The aim was to evaluate the local control (LC) rate and toxicity with 2.25-Gy radiotherapy in clinical practice and identify prognostic factors.The el...
Autores principales: | Oie, Yumi, Itoh, Yoshiyuki, Kawamura, Mariko, Takase, Yuuki, Murao, Takayuki, Ishihara, Shunichi, Nomoto, Yoshihito, Hirasawa, Naoki, Asano, Akiko, Yamakawa, Kouji, Ito, Junji, Kinoshita, Fumie, Naganawa, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nagoya University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648532/ https://www.ncbi.nlm.nih.gov/pubmed/34916724 http://dx.doi.org/10.18999/nagjms.83.4.811 |
Ejemplares similares
-
A multicenter survey of stage T1 glottic cancer treated with radiotherapy delivered in 2.25-Gy fractions in clinical practice: An initial 5-year analysis
por: Itoh, Yoshiyuki, et al.
Publicado: (2016) -
Optimized radiotherapy treatment strategy for early glottic carcinoma
por: Ono, Tamami, et al.
Publicado: (2023) -
Multi-Institutional Analysis of Early Glottic Cancer from 2000 to 2005
por: Hirasawa, Naoki, et al.
Publicado: (2012) -
Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1
por: Takase, Yuuki, et al.
Publicado: (2021) -
Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas: An initial analysis
por: Kimura, Kana, et al.
Publicado: (2017)